← Open Payments lookup

SUSHMA JANI: Open Payments

NPI 1225095714 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,913 in 74 payments from 15 companies in 2025. Trend: 2023 $1,862 · 2024 $1,769 · 2025 $1,913

Food & beverage: $1,913
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.15$296
Janssen Pharmaceuticals, Inc6$253
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$251
Supernus Pharmaceuticals, Inc.12$180
Axsome Therapeutics, Inc.3$147
Alkermes, Inc.5$125
Lundbeck LLC5$118
Otsuka America Pharmaceutical, Inc.5$115
Neuronetics, Inc.2$111
Neurocrine BioSciences, Inc.4$75

Products named: COBENFY, CAPLYTA, INVEGA SUSTENNA, Qelbree, Auvelity, ABILIFY ASIMTUFII, NEUROSTAR TMS THERAPY SYSTEM, ARISTADA.

Industry payments across MD — which companies pay providers there.